Predictive Oncology Inc. (AGPU)
NASDAQ · Technology
Predictive Oncology Inc. Operating Income 2017–2025
Predictive Oncology Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Predictive Oncology Inc. operating income for the quarter ending March 31, 2026 was -7.7 M, a 237.93% increase year-over-year.
- Predictive Oncology Inc. operating income for the twelve months ending March 31, 2026 was -16.0 M, a 45.76% increase year-over-year.
- Predictive Oncology Inc. annual operating income for 2025 was -180.9 M, a 1655.79% increase from 2024.
- Predictive Oncology Inc. annual operating income for 2024 was -10.3 M, a 14.97% decrease from 2023.
- Predictive Oncology Inc. annual operating income for 2023 was -12.1 M, a 53.45% decrease from 2022.
- Predictive Oncology Inc. annual operating income for 2022 was -26.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Predictive Oncology Inc. Operating Income — FAQ
Predictive Oncology Inc. (AGPU) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Predictive Oncology Inc.'s operating income?
Predictive Oncology Inc. (AGPU) reported operating income of -$181M for fiscal 2025.
Where can I see AGPU's operating income history?
The chart and table above show Predictive Oncology Inc.'s operating income by year and by quarter, including the growth rate.